Cargando…

Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid

Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Nathaniel W., Revello, Sonia D., Liu, Xiaojing, Zhang, Suhong, Blair, Ian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793611/
https://www.ncbi.nlm.nih.gov/pubmed/23945567
http://dx.doi.org/10.1194/jlr.M040741
_version_ 1782287084236570624
author Snyder, Nathaniel W.
Revello, Sonia D.
Liu, Xiaojing
Zhang, Suhong
Blair, Ian A.
author_facet Snyder, Nathaniel W.
Revello, Sonia D.
Liu, Xiaojing
Zhang, Suhong
Blair, Ian A.
author_sort Snyder, Nathaniel W.
collection PubMed
description Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid (oxo-ETE) and 15-oxo-ETE are COX-2/15-PGDH-derived metabolites. Stable isotope dilution (SID) chiral liquid chromatography coupled with electron capture atmospheric pressure chemical ionization (ECAPCI) single reaction monitoring (SRM) MS has been used to quantify uptake of 11-oxo-ETE and 15-oxo-ETE in both LoVo cells and human umbilical vein endothelial cells (HUVEC). Intracellular 11-oxo- and 15-oxo-ETE concentrations reached maximum levels within 1 h and declined rapidly, with significant quantitative differences in uptake between the LoVo cells and the HUVECs. Maximal intracellular concentrations of 11-oxo-ETE were 0.02 ng/4 × 10(5) cells in the LoVo cells and 0.58 ng/4 × 10(5) cells in the HUVECs. Conversely, maximal levels of 15-oxo-ETE were 0.21 ng/4 × 10(5) in the LoVo cells and 0.01 ng/4 × 10(5) in the HUVECs. The methyl esters of both 11-oxo- and 15-oxo-ETE increased the intracellular concentrations of the corresponding free oxo-ETEs by 3- to 8-fold. 11-oxo-ETE, 15-oxo-ETE, and their methyl esters inhibited proliferation in both HUVECs and LoVo cells at concentrations of 2–10 μM, with 11-oxo-ETE methyl ester being the most potent inhibitor. Cotreatment with probenecid, an inhibitor of multiple drug resistance transporters (MRP)1 and 4, increased the antiproliferative effect of 11-oxo-ETE methyl ester in LoVo cells and increased the intracellular concentration of 11-oxo-ETE from 0.05 ng/4 × 10(5) cells to 0.18 ng/4 × 10(5) cells. Therefore, this study has established that the COX-2/15-PGDH-derived eicosanoids 11-oxo- and 15-oxo-ETE enter target cells, that they inhibit cellular proliferation, and that their inhibitory effects are modulated by MRP exporters.
format Online
Article
Text
id pubmed-3793611
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher The American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-37936112013-11-01 Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid Snyder, Nathaniel W. Revello, Sonia D. Liu, Xiaojing Zhang, Suhong Blair, Ian A. J Lipid Res Research Articles Cyclooxygenases (COX) metabolize arachidonic acid (AA) to hydroxyeicosatetraenoic acids (HETE), which can then be oxidized by dehydrogenases, such as 15-hydroxyprostaglandin dehydrogenase (15-PGDH), to oxo-eicosatetraenoic acids (ETE). We have previously established that 11-oxo-eicosatetraenoic acid (oxo-ETE) and 15-oxo-ETE are COX-2/15-PGDH-derived metabolites. Stable isotope dilution (SID) chiral liquid chromatography coupled with electron capture atmospheric pressure chemical ionization (ECAPCI) single reaction monitoring (SRM) MS has been used to quantify uptake of 11-oxo-ETE and 15-oxo-ETE in both LoVo cells and human umbilical vein endothelial cells (HUVEC). Intracellular 11-oxo- and 15-oxo-ETE concentrations reached maximum levels within 1 h and declined rapidly, with significant quantitative differences in uptake between the LoVo cells and the HUVECs. Maximal intracellular concentrations of 11-oxo-ETE were 0.02 ng/4 × 10(5) cells in the LoVo cells and 0.58 ng/4 × 10(5) cells in the HUVECs. Conversely, maximal levels of 15-oxo-ETE were 0.21 ng/4 × 10(5) in the LoVo cells and 0.01 ng/4 × 10(5) in the HUVECs. The methyl esters of both 11-oxo- and 15-oxo-ETE increased the intracellular concentrations of the corresponding free oxo-ETEs by 3- to 8-fold. 11-oxo-ETE, 15-oxo-ETE, and their methyl esters inhibited proliferation in both HUVECs and LoVo cells at concentrations of 2–10 μM, with 11-oxo-ETE methyl ester being the most potent inhibitor. Cotreatment with probenecid, an inhibitor of multiple drug resistance transporters (MRP)1 and 4, increased the antiproliferative effect of 11-oxo-ETE methyl ester in LoVo cells and increased the intracellular concentration of 11-oxo-ETE from 0.05 ng/4 × 10(5) cells to 0.18 ng/4 × 10(5) cells. Therefore, this study has established that the COX-2/15-PGDH-derived eicosanoids 11-oxo- and 15-oxo-ETE enter target cells, that they inhibit cellular proliferation, and that their inhibitory effects are modulated by MRP exporters. The American Society for Biochemistry and Molecular Biology 2013-11 /pmc/articles/PMC3793611/ /pubmed/23945567 http://dx.doi.org/10.1194/jlr.M040741 Text en Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc. http://creativecommons.org/licenses/by/3.0/ Author's Choice—Final version full access. Creative Commons Attribution Unported License (http://creativecommons.org/licenses/by/3.0/) applies to Author Choice Articles
spellingShingle Research Articles
Snyder, Nathaniel W.
Revello, Sonia D.
Liu, Xiaojing
Zhang, Suhong
Blair, Ian A.
Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title_full Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title_fullStr Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title_full_unstemmed Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title_short Cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
title_sort cellular uptake and antiproliferative effects of 11-oxo-eicosatetraenoic acid
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793611/
https://www.ncbi.nlm.nih.gov/pubmed/23945567
http://dx.doi.org/10.1194/jlr.M040741
work_keys_str_mv AT snydernathanielw cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid
AT revellosoniad cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid
AT liuxiaojing cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid
AT zhangsuhong cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid
AT blairiana cellularuptakeandantiproliferativeeffectsof11oxoeicosatetraenoicacid